A recent, more advanced remote access surgery for the thyroid leaves no scar visible on the body. Since the incision is hidden inside the mouth (within the inner lip), it makes it truly scarless.
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today reported financial results for the first quarter ended March 31, 2026, and provided an operational update on botensilimab plus ...
India’s Zydus Lifesciences is in the FDA’s crosshairs once again, this time for a trio of unnamed violations at an injectables facility. Following an FDA inspection that wrapped up this week, Zydus, ...
The partnership will help advancements in cancer immunotherapy in India and globally. Credit: Corona Borealis Studio/Shutterstock. · Pharmaceutical Technology · Corona Borealis Studio/Shutterstock.
As of 2 PM, Zydus Wellness shares remained firmly in positive territory, trading nearly 10 per cent higher at ₹537.40.
The inspection closed with seven observations. Zydus Life said there were no data integrity-related observations and that it ...
Zydus has received the Food and Drug Administration’s permission for two generics. The FDA approved the company's dexamethasone tablets 1 mg. Dexamethasone is used to treat conditions such as ...
Zydus Lifesciences rose 2.23% to Rs 932.15 after the company said the US Food and Drug Administration completed a GMP surveillance inspection at its biologics injectable manufacturing facility in ...
Ivabradine is indicated to reduce the risk of hospitalisation for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with reduced left ventricular ejection ...
Feb 12 (Reuters) - India's Zydus Lifesciences and its U.S. unit will pay $120 million to Astellas Pharma as part of a deal to settle a patent dispute over the Japanese drugmaker's bladder disorder ...
Guardant Health, in partnership with Zydus Lifesciences, plans to launch a blood-based multi-cancer detection test in India, ...
Zydus Lifesciences Limited announced on March 11, 2025, that it entered into an agreement to acquire a majority stake in Amplitude Surgical. Reports state that Zydus Lifesciences has a tender offer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results